Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum

Louise Benning1, Aylin Akifova2, Bilgin Osmanodja2

  • 1Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.

Summary

Donor-derived cell-free DNA (dd-cfDNA) tracks kidney transplant rejection severity. This non-invasive marker complements histopathology, extending the rejection continuum concept to blood tests for better graft monitoring.